Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site

European Journal of Medicinal Chemistry

Volumn 33, Issue 6, 1998, Pages 451-462

  Auvray, Pierrick ^a   Moslemi, Safa ^a   Sourdaine, Pascal ^a   Galopin, Sébastien ^a   Séralini, Gilles Eric ^a   Enguehard, Cécile ^b   Dallemagne, Patrick ^b   Bureau, Ronan ^b   Sonnet, Pascal ^b   Rault, Sylvain ^b  

^a UNIVERSITÉ DE CAEN   (France)

^b CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

Author keywords

Aromatase inhibitor; Breast cancer; Horse; Indane derivative; Structure function relationship

Indexed keywords

AROMATASE INHIBITOR; CYTOCHROME P450; FORMESTANE; INDAN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME BINDING; ENZYME INHIBITION; HORSE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; THEORY;

EID: 0032099613     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80046-9     Document Type: Article

References (38)

1. [1] Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., Dodson Michael M., Mendelson C.R., Bulun S.E., Endocr. Rev. 15 (1994) 342-355.
2. [2] Sergejew T., Hartmann R.W., J. Enz. Inhib. 8 (1994) 113-122.
3. [3] Hartmann R.W., Bayer H., Grün G., J. Med. Chem. 37 (1994) 1275-1281.
4. [4] Banting L., Progr. Med. Chem. 33 (1996) 147-184.
5. [5] Griffiths C.T., Hall T.C., Saba Z., Barlow J.J., Nevinny H.B., Cancer 32 (1973) 31-37.
6. [6] Brodie A.M., J. Steroid. Biochem. Mol. Biol. 40 (1991) 255-261.
7. [7] Trunet P.E., Bhatnagar A.S., Chaudri H.A., Hornberger U., Acta Oncol. 35 (1996) 15-18.
8. [8] Wouters W., Snoeck E., De Coster R., Breast Cancer Res. Treat. 30 (1994) 89-94.
9. [9] Dukes M., Edwards P.N., Large M., Smith I.K., Boyle T., J. Steroid. Biochem. Mol. Biol. 58 (1996) 439-445.
10. [10] Howell A., Downey S., Anderson E., Eur. J. Cancer 32A (1996) 576-588.
11. [11] Miller W.R., British J. Cancer 73 (1996) 415-417.
12. [12] Poulos T.L., Finzel B.C., Howard A.J., J. Mol. Biol. 195 (1987) 687-700.
13. [13] Ravichandran K.G., Boddupalli S.S., Hasemann C.A., Peterson J.A., Deisenhofer J., Science 261 (1993) 731-736.
14. [14] Hasemann C.A., Ravichandran K.G., Peterson J.A., Deisenhofer J., J. Mol. Biol. 236 (1994) 1169-1185.
15. [15] Kao Y.C., Cam L.L., Laughton C.A., Zhou D., Chen S., Cancer Res. 56 (1996) 3451-3460.
16. [16] Tomilin A., Komarova E., Moslemi S., Auvray P., Sourdaine P., Drosdowsky M.A., Séralini G.E., IVth International Aromatase Conference, Tahoe-City, California, 1996, Abst. no. A22.
17. [17] Gaillard J.L., Silberzahn P., J. Biol. Chem. 262 (1987) 5717-5722.
18. [18] Gaillard J.L., Comp. Biochem. Physiol. 100B (1991) 107-115.
19. [19] Dintinger T., Gaillard J.L., Zwain I., Bouhamidi R., Silberzahn P., J. Steroid. Biochem. 32 (1989) 537-544.
20. [20] Almadhidi J., Séralini G.E., Fresnel J., Silberzahn P., Gaillard J.L., J. Histochem. Cytochem. 43 (1995) 571-577.
21. [21] Almadhidi J., Moslemi S., Drosdowsky M.A., Séralini G.E., J. Steroid. Biochem. Molec. Biol. 59 (1996) 55-61.
22. [22] Moslemi S., Séralini G.E., J. Enz. Inhib. 12 (1997) 241-254.
23. [23] Moslemi S., Vibet A., Papadopoulos V., Camoin L., Silberzahn P., Gaillard J.L., Comp. Biochem. Physiol. 118B (1997) 217-227.
24. [24] Moslemi S., Dintinger T., Dehennin L., Silberzahn P., Gaillard J.L., Eur. J. Biochem. 214 (1993) 569-576.
25. [25] Dallemagne P., Rault S., Pilo J.C., Foloppe M.P., Robba M., Tetrahedron Lett. 44 (1991) 6327-6328.
26. [26] Bayer H., Batz C., Hartmann R.W., Mannschreck A., J. Med. Chem. 34 (1991) 2685-2691.
27. [27] Brodie A.M.H., Garett W.M., Hendrickson J.R., Tsai-Morris C.H., Marcotte P.A., Robinson C.H., Steroids 38 (1981) 693-702.
28. [28] Schenkman J.B., Biochemistry 9 (1970) 2081-2091.
29. [29] Moslemi S., Auvray P., Sourdaine P., Drosdowsky M.A., Séralini G.E., Ann. N. Y. Acad. Sci. 839 (1998) 576-577.
30. [30] Laughton C.A., Mckenna R., Neidle S., Jarman M., McCague R., J. Med. Chem. 33 (1990) 2673-2679.
31. [31] Furet P., Batzl C., Bhatnagar A., Francotte E., Rihs G., Lang M., J. Med. Chem. 36 (1993) 1393-1400.
32. [32] Laughton C.A., Zvelebil M.J., Neidle S.A., J. Steroid. Biochem. Mol. Biol. 44 (1993) 399-407.
33. [33] Graham-Lorence S., Amarneh B., White R.E., Peterson J.A., Simpson E.R., Protein Sci. 4 (1995) 1065-1080.
34. [34] Bradford M., Anal. Biochem. 72 (1976) 248-254.
35. [35] Thompson E.A., Siiteri P.K., J. Biol. Chem. 249 (1974) 5373-5378.
36. [36] Pearlman D.A., Case D.A., Caldwell J.C., Seobe G.L., Chandra Singh U., Weiner P., Kollman P.A., AMBER 4.0, University of California, San Francisco, CA, 1991.
37. [37] Laskowski R.A., MacArthur M.W., Moss D.S., Thorton J.M., J. Appl. Cryst. 26 (1993) 283-291.
38. [38] Sippl M.J., Proteins 17 (1993) 355-362.